Music in Parkinson’s Disease Rehabilitation: Are We Heading in the Right Direction?
by Nicola Fiorente, MD, and Rocco Salvatore Calabrò, MD, PhD [...]
Letter to the Editor: Antipsychotics and Parkinson’s Disease: A Troubling Mix
Funding/financial disclosures. The authors have no conflict of interest relevant [...]
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan [...]
Stroop Test for Parkinson’s Disease with Deep Brain Stimulation: A Systematic Review
by Amer Cavalheiro Hamdan, PhD, and Mariana Drabik Vieira, MSc [...]
Abnormality of Contingent Negative Variation Correlates with Parkinson’s Disease Severity
by Plamen Tzvetanov, MD, Phd, DSc, FRCP; Ivan Lisichkov, MD, [...]
Pimavanserin in the Treatment of Parkinson’s Disease Psychosis: Meta-analysis and Meta-regression of Randomized Clinical Trials
by Zeeshan Mansuri, MD, MPH; Abhishek Reddy, MD; Ramu Vadukapuram, MD; [...]
Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease: A Case Report
by Stefania Brotini, MD Dr. Brotini is with the Movement [...]
Letters to the Editor: What About Biomarkers for Parkinson’s Disease?
Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in [...]
Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson’s Disease: A Pilot Study
by Michele Meglio, PhD Student; Enrica Olivola, MD, PhD; Marco [...]
Innovative Approaches for Slowing Disease Progression in Parkinson’s Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting
by Monica Javidnia, PhD; Mark Frasier, PhD; Ira Shoulson, MD; [...]